Lovely to meet my collaborator and long distance colleague again Fekade B Sime working to raise the bar re: opat stability of antimicrobials. Such a great partnership between 🇬🇧 and 🇦🇺 BSAC Jason Roberts CRE RESPOND andrew seaton

Fantastic to see Mark Gilchrist of our Antimicrobial Expert Advisory Group presenting at #ECCMID2024, discussing our impactful media campaign on penicillin allergies in front of AMR experts. More here: bit.ly/44mA4V3 Mark Gilchrist #ESCMIDGlobal2024

Antifungal dosing in the spotlight: Jason Roberts and Patty Mitre present findings from the SAFE-ICU study at #ESCMIDGlobal2024 #ESCMIDGlobal CRE RESPOND UQ Medicine UQ News💯

⁦ESCMID⁩ global collaboration of #pharmacists from🇿🇦S Africa USA🇺🇸 UK🇬🇧 ⁦Mark Gilchrist⁩ ⁦Cahlia Naested⁩ ⁦Dena van den Bergh⁩ ⁦Angeliki Messina⁩ ⁦International Affairs at Ohio State⁩ ⁦The Ohio State University Wexner Medical Center⁩

Published Rx magazine: UK pharmacists have strong presence at international infectious disease ESCMID conference  #ESCMIDGlobal24 rxmagazine.org/uk-pharmacists… Thank you Orlagh Mark Gilchrist cc UKCPA UKCPA Infection Committee Royal Pharmaceutical Society #PharmacyResearch

One of the key solutions to managing the threat of #antimicrobialresistance is to reduce the need for antibiotics ⬆️ efforts to promote vaccination 💉 🌍 🧼Water, hygiene and sanitation 🏥 infection control The Lancet thelancet.com/journals/lance…

Second in the world 🥈 First in the UK and Europe 🥇 We are so proud of #OurImperial community for this brilliant result in this year's QS QS World University Rankings, and here's why 🧵⬇️ #QSWUR

🆕️⚡️⚡️#AAC Ilaria Motta Catherine Berry 🆔 How much should we still worry about QTc prolongation in rifampicin-resistant tuberculosis? ECG findings from TB-PRACTECAL RCT #IDXposts journals.asm.org/doi/10.1128/aa…

Vous avez toujours voulu savoir comment se prépare le Best of de la Littérature 🗞️? Interviewé par Anne-Gaelle Venier, Gabriel BIRGAND vous révèle les coulisses de cette session phare de la #SF2H !

🆕️🔥State of the art review article #JAC 🌟s Jason Roberts Fekade B Sime Mark Gilchrist Current Practices and challenges of outpatient parenteral antimicrobial therapy #OPAT #IDXposts #bookmark Great tables🎯 academic.oup.com/jac/article/do…

BSAC is delighted to have contributed to this moment in accelerating more accurate diagnosis of UTIs, with the announcement that the £8m Longitude Prize on AMR on #AMR from Challenge Works has been awarded to a diagnostic test effective in just 45 minutes. bsac.org.uk/bsac-experts-c…

Making a case for OPAT BSAC Mark Gilchrist academic.oup.com/jac/advance-ar…

"In the wake of the COVID-19 pandemic... there is an imperative to maximize safe and effective alternatives to inpatient hospital care." andrew seaton and Mark Gilchrist make a case for outpatient parenteral antimicrobial therapy (OPAT): academic.oup.com/jac/advance-ar…

OPAT increasing in 🏴󠁧󠁢󠁳󠁣󠁴󠁿- opportunities, challenges and threats exist. andrew seaton describing the experiences to date. #opat2024 BSAC

🚨 Are you a pharmacist who recently attended an ECCMID ESCMID ECCMID/ ESCMID Global conference? If so please take a few moments to complete this survey. And share it with other attendees. 🙏 docs.google.com/forms/d/e/1FAI… Survey closes July 6th.

Landmark study for antimicrobial stewardship in Lancet Resp Med today. Large RCT in UK general practice of adults with respiratory illness found that nasal sprays (saline or gel-based) were associated with shorter duration of symptoms and at least 30% ⬇️ in antibiotics

thelancet.com/journals/lanre…

Drug-resistant infections are a global problem. They’re a threat to our health, livelihoods, healthcare systems and national economies. However, the weight of this burden is not felt equally. Not even close. ⤵️🌍 [1/3]

🆕️🔥Phase 3, RCT Pyrazinamide Safety, Efficacy, and Dosing in drug susceptible pulmonary TB: Flat dosing of pyrazinamide at 1000 mg daily would be readily implementable and could optimize treatment outcomes in drug-susceptible tuberculosis atsjournals.org/doi/abs/10.116…

Towards pharmacokinetic boosting of phenoxymethylpenicillin (penicillin-V) using probenecid for the treatment of bacterial infections By Rich Wilson Mark Gilchrist aholmes William Hope Centres for Antimicrobial Optimisation Network HPRU AMR et al. nature.com/articles/s4159… BIA research project grant